GENE ONLINE|News &
Opinion
Blog

Imfinzi
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Trials & Approvals Bladder Cancer
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Trials & Approvals Monoclonal Antibody
AZ’s Immune Checkpoint Inhibitor Flunks Head and Neck Cancer Trial
2021-02-10
M&A Rare Disease
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
R&D PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
Technology
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top